WHO Recommends Regen-COV for COVID-19 Patients at High Risk of Hospital Admission
A WHO panel of international experts and patients has recommended Regeneron's Regen-COV (casirivimab and imdevimab) for two groups of COVID-19 patients.
Ivermectin (Stromectol) For Humans
Latest
All
Latest
Hotter Weather Linked to Increases in COPD Exacerbations
Each one-degree Celsius increase in ambient temperature was associated with a 2% increase in the likelihood of COPD exacerbations in the following two days among current and former smokers with the disease.
All
Latest
Racial, Ethnic and Socioeconomic Inequities in COVID-19 Vaccinations
A study of the 9 largest US cities showed that high vaccination neighborhoods had more white residents, fewer people of color, higher incomes, and lower poverty rates; and lower historical COVID-19 death rates.
Disorders & Diseases
Latest
Surprising Early COPD Risks for US Hispanics/Latinos
US Hispanics and Latinos under age 50 had a 7.6% prevalence of COPD, which had associated risk factors including asthma, ever-smoking, and chronic sinusitis.
Pediatrics
Latest
Enzyme Could Be Major Driver of Preeclampsia
An enzyme called protein phosphatase 2 (PP2A) appears to be a major driver of preeclampsia, a dangerous pregnancy complication characterized by the development of high blood pressure and excess protein in the urine.
Products & Treatment
Latest
Raising Awareness for Pertussis Vaccinations
The American Lung Association has launched the Pertussis Educational Campaign to help educate adults living with asthma about the potential dangers of pertussis.
Smoking, Vaping & E-Cigarettes
Latest
College Students Using Marijuana More than Ever Before
Among college-aged students in 2020, marijuana use is at an all-time high, vaping has plateaued, hallucinogen use has significantly increased, and alcohol use declined.
Critical Care
Latest
Mobile Stroke Units Improved Patient Outcomes
Ischemic stroke patients treated on a mobile stroke unit (MSU) received anti-clot medication faster and ended up with less disability at 90 days, according to NEJM research.
Infectious Diseases
Latest
‘Killer’ T Cells Primed in the Spleen During Influenza Infection
Researchers have found that the spleen is an additional site for the priming of CD8+ "killer" T cells, which seek out and destroy other infected or cancerous cells.